Forest Ray

Articles Authored by Forest Ray
Assaying both CTCs and ctDNA simultaneously offers a path to more accurate and early cancer detection and drug response monitoring.
The firm is developing prognostic cancer tests targeting "master driver" genes that control cancer-related biological pathways.
A growing volume of preclinical data linking dysbiosis to unfavorable solid organ transplant outcomes such as graft rejection is fueling calls for more rigorous research.
SeekIn's Two-Step Multi-Cancer Early Detection Method May Reduce False Positives, Screening Costs
Premium
Further screening individuals who test positive by SeekIn's OncoSeek protein biomarker test with the NGS-based SeekInCare assay reduced false positives in a study.
Biofidelity Aims to Improve NGS Signal-to-Noise, MRD Testing With New Sample Enrichment Platform
Premium
Enspyre enriches mutated DNA prior to sequencing by efficiently removing non-mutated sequences and complements the firm's PCR-based Aspyre Lung platform.
The Solvd Health AvertD assay for opioid use disorder risk could lead to false negative and false positive results, according to a study led by University of Pennsylvania researchers.
Geisinger Expands Preventive Genomic Screening Capabilities With Platform Supported by AWS Grant
Premium
The new platform is expected to advance the MyCode population genomics program by being more user-friendly and automated.
Blood Test From Stanford-led Team Could Predict Vaccine Durability
Bone marrow cells called megakaryocytes produce platelets with transcriptional programs that enhance antibody response times to several vaccines.

VA Launches Prostate Cancer Screening Study to Improve Early Detection, Personalize Recommendations
Premium
The study is evaluating the utility of a prostate cancer risk prediction model based on a polygenic score, family history, and a blended genome-exome sequencing approach.
Volition Eyes East Asia Expansion With Nucleosome-Based Blood Test for Lung Cancer Screening
Premium
The firm hopes to include its lung cancer assay in Taiwan's national cancer screening program while developing sepsis and ovarian cancer assays.